Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy.
about
Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions.Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype.Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.Development of rAAV2-CFTR: History of the First rAAV Vector Product to be Used in HumansBirth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy.Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences.Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences.Apparently nonspecific enzyme elevations after portal vein delivery of recombinant adeno-associated virus serotype 2 vector in hepatitis C virus-infected chimpanzees.Reduced number of CFTR molecules in erythrocyte plasma membrane of cystic fibrosis patients.Current progress of adeno-associated-virus-based therapy for the treatment of cystic fibrosis in humans.
P2860
Q33938435-5B5BEF53-F4C8-4348-A188-A3D74126E851Q33964142-A421E844-8A20-48F4-8F95-142192297B03Q34233154-0A126E62-91B0-40C3-8C8C-C193311810F1Q36384464-64BF1D48-9C00-42C7-A26B-C084E1F54B1BQ36806347-E205B9D7-856B-4577-B4A6-C4FBA773BA95Q37316887-470A5C85-142D-4D39-B9F8-80AD44639F00Q37731874-B77F57B5-81C8-4F4F-B7B3-29768357B57EQ40257549-0878441C-A6A6-4896-BA01-163BD385E02FQ40258000-33C8EBA1-3AA8-48F6-ADDB-4459CDFF6BF0Q42425973-7EFD4495-CE74-417E-957F-2F43B89A0EA3Q50724217-645F54E7-620F-4A01-A59D-BC6A913B6EDDQ55175086-32BEE98B-BE4E-4E10-99FA-348C432214B6
P2860
Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Correlation between DNA transf ...... virus serotype 2 gene therapy.
@en
Correlation between DNA transf ...... virus serotype 2 gene therapy.
@nl
type
label
Correlation between DNA transf ...... virus serotype 2 gene therapy.
@en
Correlation between DNA transf ...... virus serotype 2 gene therapy.
@nl
prefLabel
Correlation between DNA transf ...... virus serotype 2 gene therapy.
@en
Correlation between DNA transf ...... virus serotype 2 gene therapy.
@nl
P2093
P356
P1433
P1476
Correlation between DNA transf ...... virus serotype 2 gene therapy.
@en
P2093
Barrie J Carter
Erik M Schwiebert
Terence R Flotte
William B Guggino
P304
P356
10.1089/HUM.2005.16.921
P577
2005-08-01T00:00:00Z